Black Rock Inc. Syros Pharmaceuticals, Inc. Transaction History

Black Rock Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.78 - $8.9 $1.19 Million - $13.6 Million	-1,524,309 Closed	0 $0
Q2 2022 Aug 12, 2022	SELL	$0.69 - $1.21 $1.83 Million - $3.2 Million	-2,645,832 Reduced 63.45%	1,524,309 $1.47 Million
Q1 2022 May 12, 2022	SELL	$1.02 - $3.8 $63,369 - $236,082	-62,127 Reduced 1.47%	4,170,141 $4.96 Million
Q4 2021 Feb 10, 2022	SELL	$3.26 - $4.66 $395,777 - $565,742	-121,404 Reduced 2.79%	4,232,268 $13.8 Million
Q3 2021 Nov 09, 2021	SELL	$4.08 - $5.66 $447,510 - $620,811	-109,684 Reduced 2.46%	4,353,672 $19.5 Million
Q2 2021 Aug 11, 2021	BUY	$5.01 - $7.48 $22.4 Million - $33.4 Million	4,463,356 New	4,463,356 $24.3 Million

Ticker SYRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,236,200
Market Cap $4.86M
Description
Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically def...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.